Vectans PharmaVectans PharmaVectans PharmaVectans Pharma
  • ABOUT US 
    • Overview
    • Leadership
      • Governance
      • Board
    • Our purpose
    • Global footprint
      • Our global reach
      • Partners
    • Press releases
    • News
  • Our science 
    • Drug optimization
    • Lauriad® technology
      • Overview
      • How it works
      • Scientific publications
    • Lauriad® applications
  • OUR MEDICINES 
    • PIPELINE
    • Commercialized medicines 
      • Sitavig®
      • Loramyc®
  • PARTNER WITH US 
    • Commercial & Industrial partners
    • Academic & Research collaborations
    • Careers
      • Working at Vectans Pharma
      • Join us
  • CONTACT
  • Français

Nomination of François Boutignon as Chief Innovation and Technology Officer

Read the press release

Last news

  • Exclusive agreement with the Menarini group and Berlin Chemie for Sitavig®
  • Exclusive agreement with the Menarini group and Berlin Chemie
  • Season's greetings
  • Vectans Pharma participated in a symposium about new treatments in Oropharyngeal Candidiasis
  • CPhI Worldwide 2022 in Frankfurt, November 1st-3rd
230 Bureaux de la colline
92213 Saint-Cloud
France

contact@vectans.com

logo-footer-10

  FOLLOW US

Copyright © VECTANS PHARMA

Legal notices and privacy policy